# Biocardia (BCDA) — Earnings

BCDA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bcda/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.13 |
| EPS estimate | −$0.18 |
| EPS surprise | +27.78% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 12, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/925741/000143774926027315/bcda20260806_10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/df49c1be-26bc-7c1f-5421-146cbf8238af.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 12, 2026 | −$0.18 | −$0.13 | 27.78% | — | — |
| Q1 2026 | May 15, 2026 | −$0.17 | −$0.21 | -27.27% | — | — |
| Q4 2025 | Mar 24, 2026 | −$0.17 | $0.00 | 100.00% | — | — |
| Q3 2025 | Nov 12, 2025 | −$0.23 | −$0.24 | -4.35% | — | — |
| Q2 2025 | Aug 11, 2025 | −$0.50 | −$0.40 | 20.00% | — | — |
| Q1 2025 | May 14, 2025 | $0.00 | −$0.59 | 0.00% | — | — |
| Q4 2024 | Mar 26, 2025 | −$0.63 | −$0.06 | 90.40% | $22,500.00 | $25,000.00 |
| Q3 2024 | Nov 13, 2024 | −$1.19 | −$0.61 | 48.74% | $200,000.00 | — |
| Q2 2024 | Aug 13, 2024 | −$0.10 | −$0.88 | -780.00% | $50,000.00 | $3,000.00 |
| Q1 2024 | May 14, 2024 | −$3.00 | −$1.35 | 55.00% | — | $55,000.00 |
| Q4 2023 | Mar 27, 2024 | −$1.13 | −$1.35 | -20.00% | $190,000.00 | $17,000.00 |
| Q3 2023 | Nov 8, 2023 | −$1.80 | −$1.80 | 0.00% | $50,000.00 | $357,000.00 |
| Q2 2023 | Aug 9, 2023 | −$2.35 | −$2.55 | -8.51% | $183,500.00 | $43,000.00 |
| Q1 2023 | May 10, 2023 | −$2.40 | −$2.55 | -6.25% | $340,000.00 | $64,000.00 |
| Q4 2022 | Mar 29, 2023 | −$2.70 | −$2.55 | 5.56% | $153,000.00 | $112,000.00 |
| Q3 2022 | Nov 9, 2022 | −$3.41 | −$2.55 | 25.27% | $113,000.00 | $212,000.00 |
| Q2 2022 | Aug 10, 2022 | −$3.72 | −$2.10 | 43.55% | $92,000.00 | $974,000.00 |
| Q1 2022 | May 11, 2022 | −$2.48 | −$2.85 | -15.15% | $190,000.00 | $60,000.00 |
| Q4 2021 | Mar 29, 2022 | −$2.51 | −$3.15 | -25.37% | $32,750.00 | $80,000.00 |
| Q3 2021 | Nov 10, 2021 | −$3.15 | −$2.40 | 23.81% | $30,000.00 | $821,000.00 |

## Frequently Asked Questions

### When did Biocardia (BCDA) last report earnings?

Biocardia last reported on Aug 12, 2026, covering fiscal Q2 2026.

### Did BCDA beat earnings estimates?

Yes. Biocardia reported EPS of −$0.13 for Q2 2026 against a −$0.18 estimate — a 27.78% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).